The PATHWAY anti-HER2 (4B5) Antibody assay is a laboratory test designed to detect HER2 protein in patients with breast cancer. If the test shows that a patient’s breast cancer does have...

HER2/neu (4B5) Rabbit Monoclonal Primary Antibody, VENTANA, one of over 250 optimized pre-diluted reagents for use on the BenchMark IHC/ISH automated slide staining instruments by …

PATHWAY HER2/neu (4B5) Rabbit Monoclonal Primary Antibody, one of over 250 optimized pre-diluted reagents for use on the BenchMark IHC/ISH automated slide staining instruments by …

6 days ago · The PATHWAY HER2 (4B5) test is now FDA-approved to assess HER2-ultralow status in metastatic breast cancer, expanding its prior HER2-low indication. The FDA has …

PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal (the “HER2 (4B5) assay”) is directed against the internal domain of the c-erbB-2 oncoprotein (HER2). HER2 oncoprotein was cloned and …

Jan 31, 2025 · FDA approval of PATHWAY HER2 (4B5) test expands diagnostic capabilities for HER2-ultralow metastatic breast cancer, enabling targeted treatment with trastuzumab …

The Roche HER2 (4B5) clone achieves consistently high-proficiency assessment scores compared to other clones 9 and demonstrates high concordance with HER2 FISH, 10,11 …

Oct 8, 2022 · The PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody was approved by the FDA as a companion diagnostic to help identify patients with HER2-low …

Nov 25, 2024 · The Roche HER2 (4B5) clone achieves consistently high proficiency assessment scores compared to other clones(9) and demonstrates high concordance with HER2 …

VENTANA anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody [VENTANA HER2 (4b5)] is intended for the semi-quantitative detection of HER2 antigen in sections of formalin-fixed, …